Colorectal Cancer
Colorectal Cancer
Colorectal Cancer
Henry Yao
HMO1, Royal Melbourne Hospital
Colorectal Cancer
Epidemiology
Most common internal cancer in Western Societies
Second most common cancer death after lung cancer
Lifetime risk
1 in 10 for men
1 in 14 for women
Generally affect patients > 50 years (>90% of cases)
Colorectal Cancer
Forms
Hereditary
Family history, younger age of onset, specific gene defects
E.g. Familial adenomatous polyposis (FAP), hereditary
nonpolyposis colorectal cancer (HNPCC or Lynch syndrome)
Sporadic
Absence of family history, older population, isolated lesion
Familial
Family history, higher risk of index case is young (<50years)
and the relative is close (1st degree)
Histopathology
Generally adenocarcinoma
Risk Stratification
Risk factors
Past history of colorectal cancer, pre-existing adenoma,
ulcerative colitis, radiation
Family history 1st degree relative < 55 yo and relatives
with identified genetic predisposition (e.g. FAP, HNPCC,
Peutz-Jeghers syndrome) = more risk
Diet carcinogenic foods
Risk category (for asymptomatic pts)
Category 1 (2x risk) 1o or 2o relative with colorectal cancer
>55 yo
Category 2 (3~6x) 1o relative < 55yo or 2 of 1o or 2o
relative at any age
Category 3 (1 in 2) HNPCC, FAP, other mutations
identified
Screening
Group
Screening
Evidence
General Population
1A
Category 1
Category 2
IIIB
Category 3
IIIB
Clinical Presentation
Depends on location of cancer
Locations
in descending colon and rectum
in sigmoid colon and rectum (i.e. within reach of
flexible sigmoidoscope)
Caecal and right sided cancer
Iron deficiency anaemia (most common)
Distal ileum obstruction (late)
Palpable mass (late)
Clinical Presentation
Clinical Presentation
Local invasion
Bladder symptoms
Female genital tract symptoms
Metastasis
Liver (hepatic pain, jaundice)
Lung (cough)
Bone (leucoerythroblastic anaemia)
Regional lymph nodes
Peritoneum (Sister Marie Joseph nodule)
Others
Examination
Investigations
Investigations
Colonoscopy
Can visualize lesions < 5mm
Small polyps can be removed or at a later stage by
endoscopic mucosal resection
Performed under sedation
Consent: bleeding, infection, perforation (1 in 3000), missed
diagnosis, failed procedure, anaesthetic/medical risks
Warn: bowel prep, abdominal bloating/discomfort afterwards,
no driving for 24 hours
Bowel Prep
Investigations
Other Imaging
CT colonoscopy
Endorectal ultrasound
Determine: depth, mesorectal lymph node involvements
No bowel prep or sedation required
Help choose between abdominoperineal resection or ultra-low
anterior resection
CT and MRI staging prior to treatment
Blood tests
FBE anaemia
Coagulation studies for surgery
UECr - ?take contrast, ?NAC required
Tumour marker CEA
Useful for monitoring progress but not specific for diagnosis
Management
Pre-operative
Bowel prep picolax, go lytely, fleet
Normally 1 day prior
Partial obstruction 2~3 days prior
Complete obstruction intra-operative lavage
Antibiotics prophylaxis (up to 24 hours post-op)
Ampicillin
Metronidazole
Gentamicin
DVT/PE prophylaxis
Arterial supply
Resection
Management
Management
Sigmoid colon
High anterior resection
Vessels ligated inferior mesenteric, left colic and sigmoid
Anastomoses of mid-descending colon to upper rectum
Obstructing colon carcinoma
Right and transverse colon resection and primary anastomosis
Left sided obstruction
Hartmanns procedure proximal end colostomy (LIF) +
oversewing distal bowel + reversal in 4-6 months
Primary anastamosis subtotal colectomy (ileosigmoid or
ileorectal anastomosis)
Intraoperative bowel prep with primary anastomosis (5% bowel
leak)
Proximal diverting stoma then resection 2 weeks later
Palliative stent
Rectal Cancer
Options
Low anterior resection
Transanal local excision
Abdomino-perineal resection
Palliative procedure
Factors influencing choice
Level of lesion distance from dentate line, <5cm requires
abdomino-perineal resection to obtain adequate margin
Note: only 3% of tumours spread beyond 2cm
Rectal Cancer
Anterior resection
Upper and mid rectum cacinoma
Sigmoid and rectum resected
Vessels divided inferior mesenteric and
left colic
Mesorectum resected
Coloanal anastomosis
High intraperitoneal anastamosis
(upper 1/3 of rectum)
Low extra-peritoneal anastomosis
Post-op recovery
Increased stool frequency
12-18 month to acquire normal bowel
function
1~4% anastamotic leak
Rectal Cancer
Abdominoperineal resection
Larger T2 and T3 or poorly differentiated
tumour
Rectum mobilised to pelvic floor through
abdominal incision
Sigmoid end colostomy
Separate perianal elliptical incision to
mobilise and deliver anus and distal
rectum
Vessels ligated inferior mesenteric
Rectal Cancer
Hartmanns procedure
Acute obstruction
Palliative
Transanal local exision
Early stage
Too low to allow restorative surgery
En block resection for locally advanced colorectal carcinoma
(remove adherent viscera and abdominal wall)
Palliative procedures
Diverting stoma
Radiotherapy
Chemotherapy
Local therapy laser, electrocoagulation, cryosurgery
Nerve block
Staging
TNM Staging
Stage 0 Tis N0 M0 i.e. small tumour within the lining of the colon
or rectum
Stage 1 T1 N0 M0 or T2 N0 M0 i.e. tumour has invaded layers of
the colon without spread beyond wall
Stage 2 T3 N0 M0 or T4 N0 M0 i.e. tumour has spread beyond
wall and into nearby tissue but no LNs
Stage 3 Any T with any N but M0 i.e. spread to nearby LNs but not
to other organs
Stage 4 Any T with any N and M1 i.e. spread to other organs (e.g.
liver and lungs)
Dukes staging
Duke A tumour confined to bowel wall
Duke B tumour invading through serosa
Duke C lymph node involvement
Distant metastasis
Wholistic care
Education and counselling (about risk in family members as well)
Lifestyle management diet changes
Support from cancer council
Surgical (hemicolectomy, stents for palliation)
Stage 0 and 1 surgical resection only with NO adjuvant chemo (NNT to high and SE
of chemo too high)
Stage 2,3,4 surgery, chemotherapy, radiotherapy, targeted therapy
Prepare patient for surgery explain diagnosis, surg under GA, hospital for 7d, bowel
prep, proph antibiotics, primary anastomosis, may require colostomy or ileostomy to
facilitate healing but temp and only for 12wk, risk is infection, bleeding, anastomotic
leak, mortality
Medical
Adjuvant chemo FOLFOX (folinic acid, 5-FU, oxaliplatin) increase 5yr survival, be
wary of oxaliplatin causing peripheral neuropathy
Biological therapy anti-VEGF (bevacizumab), EGFR inhibitor (cetuximab)
Radiotherapy for palliation or liver mets
Follow-up
Aim to detect local recurrence, metastasis or new primary
CEA only useful if high b4 surg and low after surg
FOBT, repeat CT, colonoscopy according to hospital protocol
Complications
Liver metastasis resection, embolisation,
chemotherapy, RFA, cryotherapy
Local invasion perineal and pelvic pain
Bowel obstruction
Palliated surgically (colectomy, stoma, stent placed
endoscopically) or else syringe driver (mix of
analgesic, anti-emetic, anti-spasmotic)
Fistula to skin or bladder
Rectal discharge and bleeding
Hypoproteinaemia (from poor appetite and absorption
peripheral oedema)
Poor appetite (steroids can help)
Prognosis
5 yr survivals
T1 = >90%, T2 = >80%. T3 = >50%
LN involvement = 30~40%
Distant mets = <5%
References
Case Scenario
Differential diagnosis
Common causes
Haemorrhoids
Colorectal cancer
Diverticular disease
Anorectal pathology
Haemorrhoids, anal fissure, anorectal cancer, anal prolapse
Colonic pathology
Colorectal polyp/cancer, diverticular disease, angiodysplasia
Colitis (IBD, infective, pseudomembranous colitis, ischaemic,
radiation)
Post-surgery (e.g. polypectomy)
Small intestine and stomach pathology
Massive upper GI bleed haematochezia
Meckels diverticulum, small bowel angiodysplasia
History
Case Scenario
Doc, Ive been noticing
blood in my stool for 6
months now.
The blood seems to be
mixed in the stool.
Ive also noticed some
constipation recently. This
is unusual for me. I
usually go every day.